Physician profile
Durga P Sunkara
NPI 1194765743
$2,975.30
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $540 · 2021: $683 · 2022: $677 · 2023: $292 · 2024: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $684.03 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $450.24 | 2019-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $345.65 | 2021-2023 | |
| Amarin Pharma, INC. | $309.61 | 2019-2021 | |
| Abbvie INC. | $290.45 | 2021-2024 | Dalvance, Qulipta, Ubrelvy |
| Amgen INC. | $127.19 | 2019-2021 | |
| Astellas Pharma US INC | $124.35 | 2019-2022 | |
| Allergan, INC. | $101.79 | 2019-2020 | |
| Lilly USA, LLC | $100.77 | 2020-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $67.31 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $64.70 | 2022-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.00 | 2021-2022 | |
| Inspire Medical Systems, INC. | $44.84 | 2024 | Inspire |
| Abbott Laboratories | $42.89 | 2022-2024 | Proclaim |
| Almatica Pharma LLC | $41.10 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $35.10 | 2022-2023 | Xarelto |
| Biogen, INC. | $19.90 | 2021 | |
| Idorsia Pharmaceuticals US INC | $16.43 | 2022 | |
| Exact Sciences Corporation | $15.93 | 2023 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.44 | 2021 | |
| Shire North American Group INC | $12.12 | 2019 | |
| Genentech USA, INC. | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Durga Sunkara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.